Article info
Inflammatory bowel disease
Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn’s disease: a randomised, double-blind, placebo-controlled, phase 2 study
- Correspondence to Dr J F Valentine, Gastroenterology, Hepatology & Nutrition, University of Florida, 1600 SW Archer Rd, Rm HD 602, Gainesville, FL 32610, USA; John.Valentine{at}medicine.ufl.edu
Citation
Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn’s disease: a randomised, double-blind, placebo-controlled, phase 2 study
Publication history
- Revised March 31, 2009
- Accepted April 28, 2009
- First published June 7, 2009.
Online issue publication
September 11, 2009
Article Versions
- Previous version (7 June 2009).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and British Society of Gastroenterology. All rights reserved.